Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Agriculture
- Food and Beverage
- Environmental
- University / Academia / Research
- Water and Wastewater
- Manufacturing, Other
- Mining
- Pulp & Paper
- Health and Safety
- Air and Climate
- Government
- Glassware
- Metal
- Waste and Recycling
- Oil, Gas & Refineries
- Soil and Groundwater
- Energy
Monoclonal Antibody Suppliers & Manufacturers
228 companies found
Premium
based inFramingham, MASSACHUSETTS (USA)
SCIEX empowers you to solve the most impactful analytical challenges in quantitation and characterization in environmental testing. With groundbreaking innovation and outstanding reliability and support, SCIEX has been at the forefront of the field ...
Perform consistent and compliant biotherapeutics characterization faster than ever. With the PA 800 Plus system, you can confidently safeguard the success of your biologics. Run multiple characterizations from a single system that biopharma labs ...
based inCambridge, UNITED KINGDOM
Biosceptre is a biopharmaceutical company focused on chimeric antigen receptor (CAR) T-cell therapy and immune-oncology treatment, that’s committed to bringing a new range of targeted therapies to a wide range of cancer patients. With Nobel ...
We are also developing antibodies that specifically target nfP2X7 for use in both solid and haematological tumours. Our preclinical data is very promising and studies show an excellent safety profile. By exploiting the modular ...
based inRochester Hills, MICHIGAN (USA)
Oxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins and antibodies for biomedical research and drug discovery. The company’s primary focus is on the identification and assay of biomarkers for ...
based inCounty of New Castle, DELAWARE (USA)
MedGenome Inc. is a global leader in personalized medicine with unique genomic solutions in immuno-oncology, diabetes, ophthalmology, cardiology and other rare diseases. Founded in 2013, MedGenome currently has a Next Generation Sequencing (NGS) ...
Antibody discovery is an important component for early-stage research studies, diagnostics, and therapeutics. Hybridoma technology has been the forefront tool in generating monoclonal antibodies but ...
based inSantiago de Compostela, SPAIN
We are a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer. Our patented MPN Technology enables the discovery and development of new compounds involving intracellular ...
Our patented MPN Technology® enables the discovery and development of new compounds involving intracellular biologics, especially monoclonal antibodies (mAbs), to successfully engage previously undruggable ...
based inVictoria, BRITISH COLUMBIA (CANADA)
IPA (ImmunoPrecise Antibodies NASDAQ: IPA ) is a biotherapeutic research company that brings industry leading antibody discovery services and complex artificial intelligence technologies together - to lead its pharmaceutical partners into the era of ...
Our genetic immunization protocols have proven successful in the generation of monoclonal antibodies against new, challenging, and conformation-sensitive targets, and have been successfully applied in transgenic ...
based inAhrensburg, GERMANY
ulti med Products (Deutschland) GmbH specialises in the development, manufacture as well as worldwide export of high-quality In-vitro diagnostics and drug tests. The high quality standards applicable to our products and our quality management system ...
This kit is used for the in vitro qualitative detection of 2019-nCoV antigen. It is an immunochromatography sandwich assay, and intended to detect 2019-nCoV N-protein antigen in human nasal (NS) swab specimens. This kit can be used for individuals ...
based inElectronic City, INDIA
We are a global biopharmaceutical company with the belief that everyone, everywhere deserves access to affordable quality medicines. Our pioneering spirit paved the way for biotechnology in India, and we continue to apply the same spirit in finding ...
Biocon Biologics’ Research and Development organisation is fully integrated to develop high-quality biosimilars (recombinant insulins, monoclonal antibodies and other protein therapeutics) that can be ...
based inFremont, CALIFORNIA (USA)
Bionova Scientific is a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture processes. Bionova’s founders believed that the best way to build a scientific services business was to bring ...
based inEmeryville, CALIFORNIA (USA)
BiosPacific, Inc. was founded in 1989 as a supplier of immunological reagents to the commercial diagnostic industry. Our strength over the years has been to consistently meet the demands of this dynamic industry and our diverse customer base. Over ...
Product: ACTH N-Terminal Monoclonal Antibody. Source: Cell culture. Immunogen: KLH conjugate. Purification Method: Protein A affinity chromatography. Buffer: PBS, pH 7.2. Preservative: 10mM NaN3. Subclass: IgG1. ...
based inSão Paulo, BRAZIL
Blau Farmacêutica is currently one of the leading Pharmaceutical companies of Latin America, producing highly complex and hospital medicines, essential for human health. Blau is a leading pharmaceutical industry in the institutional segment and a ...
based inMalvern, PENNSYLVANIA (USA)
Shifa Biomedical Corporation (Shifa) is a drug discovery company in Malvern Pennsylvania. It is a privately held biopharmaceutical company dedicated to the cost-effective development of drugs for the treatment of cardiovascular disease. ...
LDLR is a cell-surface receptor that binds LDL-C and carries it into cells to the endosome for degradation and thus reduces the plasma level of LDL-C (Figure 1). However, PCSK9 controls the degradation of the LDLR in the liver (Figure 1) and ...
based inSomerset, NEW JERSEY (USA)
As the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world, we conduct all our business responsibly and with integrity. Our ...
At Catalent Biologics, we understand the increasingly complex analytical and regulatory requirements for biologics and other large molecules and also new technologies and techniques that can be employed. We offer one of the broadest ranges of ...
based inSeoul, SOUTH KOREA
Eutilex is Developing anti-tumor T cell therapy and antibody therapeutics based on its own proprietary immunotherapy technology We set a goal to be a leading company in anti-tumor immunotherapy markets through the technical innovation & early ...
Fully humanized anti-human 4-1BB monoclonal antibody. Agonistic effect of EU101 promotes cytotoxic T lymphocyte response and it leads to eradication of ...
based inSuwon-si, SOUTH KOREA
We are continually challenging ourselves to become a leading company specialized in in-vitro diagnostics and dedicated to creating value for human health innovation. We are the pioneers of diagnostic kit and technology, specializing in the area of ...
based inGeneva, SWITZERLAND
Abologix is a biopharmaceutical company based in Geneva, Switzerland. The company is a spin out from the laboratories of Prof. Beat Imhof and Thomas Matthes at the University of Geneva and the Geneva University Hospitals. The company is developing ...
Olfactomedin-like protein 3 (Olfml3) creates an angiogenic environment in tumours and is associated with vascular growth factors BMP-4 and PDGF. Olfml3 is overexpressed in some cancers. Blocking Olfml3 with highly specific ...
based inHeidesee, GERMANY
As a leading developer and manufacturer in vitro diagnostics and reagents for enzyme immunoassays especially of ready-to-use substrates, Seramun Diagnostica GmbH is your partner when it comes to meet special requirements, ensuring highest-level ...
Polyclonal antibodies are raised in sheep and rabbits. Balb/c mice are used for monoclonal antibody production. Non- infectious, non-toxic antigens are provided by the customers. Special ...
based inMinneapolis, MINNESOTA (USA)
Cell Culture Company delivers whole cell pellets, cell lysates, custom monoclonal antibody and recombinant protein manufacturing services from development to commercialization. We employ traditional cell culture methods as well as automated, ...
Are you looking for recombinant antibody production services for antibody characterization, screening, or preclinical studies? Cell Culture Company offers a wide selection of offerings to meet your needs. With our 40+ years of experience ranging ...
based inCAEN, FRANCE
Lys Therapeutics, first-in-class biotherapies against neurological diseases. Lys Therapeutics is a French biotech company developing innovative drugs to treat patients suffering from neurovascular or neurodegenerative disorders, including stroke and ...
Glunomab / Glunozumab®: a monoclonal antibody counteracting the strong toxicity triggered by the interaction of an endogenous protease, tissue plasminogen activator (tPA) with NMDA receptors ...
based inPalo Alto, CALIFORNIA (USA)
Immune-Onc is a clinical-stage company developing a novel class of myeloid checkpoint inhibitors. We believe myeloid checkpoints are the next frontier of immunotherapy for cancer. In collaboration with scientists, our research team is among the ...
Immune-Onc’s lead program is IO-202, an antagonist antibody targeting the myeloid checkpoint LILRB4 (also known as ILT3). Immune-Onc has a Phase I trial underway to evaluate IO-202 as a potential treatment for acute myeloid leukemia (AML) and ...